Skip to main content
SpringerLink
Log in

Heart failure with a preserved ejection fraction and the EMPEROR-Preserved Trial: a review of how we got here

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Heart failure with a preserved ejection fraction (HFpEF), previously known as diastolic heart failure, was first recognized more than 50 years ago. In spite of all the advances in the knowledge of HFpEF, important questions remain, namely the fact that no therapy has been shown to improve outcomes in these patients. The EMPEROR-Preserved Trial, a trial on the use of empagliflozin on patients with HFpEF, published in October 2021, was the first trial to ever show a change in outcomes in these patients. This article reviews the history of HFpEF and the problems related to its definition and diagnosis over time, and critically reviews the results of the EMPEROR-Preserved Trial in light of these.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Bohm M et al (2021) Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 385(16):1451–1461. https://doi.org/10.1056/NEJMoa2107038

    Article  CAS  PubMed  Google Scholar 

  2. Redfield MM (2016) Heart failure with preserved ejection fraction. N Engl J Med 375(19):1868–1877. https://doi.org/10.1056/NEJMcp1511175

    Article  PubMed  Google Scholar 

  3. Komajda M, Lam CS (2014) Heart failure with preserved ejection fraction: a clinical dilemma. Eur Heart J 35(16):1022–1032. https://doi.org/10.1093/eurheartj/ehu067

    Article  CAS  PubMed  Google Scholar 

  4. Rossignol P, Hernandez AF, Solomon SD, Zannad F (2019) Heart failure drug treatment. The Lancet 393(10175):1034–1044. https://doi.org/10.1016/s0140-6736(18)31808-7

    Article  CAS  Google Scholar 

  5. Gelzinis TA, Tawil J (2016) Differential diagnosis and clinical management of diastolic heart failure: current best practice. Research Reports in Clinical Cardiology 7:117–135. https://doi.org/10.2147/rrcc.S80291

    Article  Google Scholar 

  6. Drazner MH (2021) SGLT2 Inhibition in heart failure with a preserved ejection fraction — a win against a formidable foe. N Engl J Med 385:1522–4

  7. Braunwald E (2021) Heart failure with preserved ejection fraction: a stepchild no more! Eur Heart J 42(38):3900–3901. https://doi.org/10.1093/eurheartj/ehab601

    Article  PubMed  Google Scholar 

  8. Harvey W, Harvey W, Harvey W, Riolan J (1737) Jerry and Gene Jones Jefferson Collection (Library of Congress). Exercitatio anatomica de motu cordis et sanguinis in animalibus : cui accedunt Exercitationes duae anatomicae de circulatione sanguinis ad Joannem Riolanum filium. Editio novissima, indice ornata. ed. Lugduni Batavorum: Apud Johannem van Kerckhem

  9. Robin ED, Burwell CS (1957) Hemodynamic aspects of diffuse myocardial fibrosis. Circulation 16(5):730–735. https://doi.org/10.1161/01.cir.16.5.730

    Article  CAS  PubMed  Google Scholar 

  10. Goodwin JF, Gordon H, Hollman A, Bishop MB (1961) Clinical aspects of cardiomyopathy. Br Med J 1(5219):69–79. https://doi.org/10.1136/bmj.1.5219.69

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Stewart S, Mason DT, Braunwald E (1968) Impaired rate of left ventricular filling in idiopathic hypertrophic subaortic stenosis and valvular aortic stenosis. Circulation 37(1):8–14. https://doi.org/10.1161/01.cir.37.1.8

    Article  CAS  PubMed  Google Scholar 

  12. Vasan RSBEJ, Levy D (1995) Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. JACC 26(7):1565–1574

    Article  CAS  Google Scholar 

  13. Failure ESGoDH (1998) How to diagnose diastolic heart failure. Eur Heart J (19):990–1003

  14. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE et al (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28(20):2539–2550. https://doi.org/10.1093/eurheartj/ehm037

    Article  PubMed  Google Scholar 

  15. Pieske B, Tschope C, de Boer RA, Fraser AG, Anker SD, Donal E et al (2019) How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 40(40):3297–3317. https://doi.org/10.1093/eurheartj/ehz641

    Article  PubMed  Google Scholar 

  16. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726. https://doi.org/10.1093/eurheartj/ehab368

    Article  CAS  PubMed  Google Scholar 

  17. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–847. https://doi.org/10.1093/eurheartj/ehs104

  18. Logue RBRPH (1970) Differential diagnosis of congestive heart failure. Progress in Cardiovascular Diseases XIII(4):55

  19. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al (2016) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–200. https://doi.org/10.1093/eurheartj/ehw128

  20. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18(12):1440–1463. https://doi.org/10.1016/j.echo.2005.10.005

    Article  PubMed  Google Scholar 

  21. Aurigemma GPGWH (2004) Diastolic Heart Failure. N Engl J Med 351:1097–105

  22. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS et al (2001) ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Am Coll Cardiol 38(7):2101–2113. https://doi.org/10.1016/s0735-1097(01)01683-7

    Article  CAS  PubMed  Google Scholar 

  23. Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP et al (2019) Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med 381(17):1609–1620. https://doi.org/10.1056/NEJMoa1908655

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Serviço de Medicina, Hospital do Espírito Santo-Évora E.P.E, Évora, Portugal

    Tiago Tribolet de Abreu

Authors
  1. Tiago Tribolet de Abreu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tiago Tribolet de Abreu.

Ethics declarations

Ethics approval

The manuscript does not contain clinical studies or patient data.

Conflict of interest

The author declares no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tribolet de Abreu, T. Heart failure with a preserved ejection fraction and the EMPEROR-Preserved Trial: a review of how we got here. Heart Fail Rev 27, 2077–2082 (2022). https://doi.org/10.1007/s10741-022-10244-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-022-10244-8

Keywords

Search

Navigation